bioAffinity Technologies, Inc（BIAF, BIAFW）美股招股说明书 S-1（2026-06-12首版）（英文版）（103页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on June 12,2026 Registration Statement No.333-*UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM S-1 REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 bioAffinity Technologies,Inc.(Exact name of reg

2、istrant as specified in its charter)Delaware 8731 46-5211056(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)3300 Nacogdoches Road,Suite 216San Antonio,Texas 78217(210)698-5334(Address,including z

3、ip code and telephone number,including area code of registrants principal executive offices)Maria ZannesChief Executive OfficerbioAffinity Technologies,Inc.3300 Nacogdoches Road,Suite 216San Antonio,Texas 78217(210)698-5334(Name,address,including zip code,and telephone number,including area code,of

4、agent for service)Copies to:Richard A.Friedman,Esq.Sean F.Reid,Esq.Sheppard,Mullin,Richter&Hampton LLP30 Rockefeller PlazaNew York,NY 10112-0015Tel.:(212)653-8700Ross D.Carmel,Esq.Jeffrey Wofford,Esq.Sichenzia Ross Ference Carmel LLP1185 Avenue of the Americas,26th FloorNew York,NY 10036Phone:(212)9

5、30-9700 Approximate date of commencement of proposed sale to the public:As soon as practicable after the date this registration statement becomes effective.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule415 under the Securiti

6、es Act of 1933 check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,pleasecheck the following box and list the Securities Act registration statement number of the earlier effective registration statement forth